Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Diabetes Publish Ahead of Print published online ahead of print December 14, 2007
DOI: 10.2337/db07-1356

This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
db07-1356v1
57/3/606    most recent
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Friedman, J. E.
Right arrow Articles by Catalano, P. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Friedman, J. E.
Right arrow Articles by Catalano, P. M.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Original Research

Increased Skeletal Muscle TNF-{alpha} and Impaired Insulin Signaling Persists in Obese GDM Women 1 Year Postpartum

Jacob E. Friedman1, John P. Kirwan2,,4, Ming Jing3, Larraine Presley3, and Patrick M. Catalano3,,5

1Departments of Pediatrics and Biochemistry & Molecular Genetics, University of Colorado at Denver and Health Sciences Center, Aurora, CO 80045
2Departments of Pathobiology and Gastroenterology/Hepatology, Cleveland Clinic, Cleveland, OH 44195
3Department of Reproductive Biology and
4Department of Nutrition, School of Medicine, Case Western Reserve University, Cleveland OH 44106; and
5Schwartz Center for Metabolism and Nutrition, MetroHealth Medical Center, Cleveland, OH 44109

Objective.: Women with GDM demonstrate chronic and progressive insulin resistance and a markedly increased risk of converting to type 2 diabetes after pregnancy, however the cellular mechanisms underlying this insulin resistance is unknown.

Research Design and Methods.: We investigated the progression of insulin resistance in nine obese women with GDM during late pregnancy (30–36 weeks) and 1 year postpartum. Skeletal muscle biopsies were obtained at each visit and insulin resistance was determined by hyperinsulinemic-euglycemic clamp technique.

Results.: Insulin resistance was not significantly improved in GDM women (4.1±0.4 vs. 5.8±1.1 10–2 mg·kgFFM·min–1/µU·ml–1). Subjects did not experience significant weight loss postpartum. Body weight, fat mass, fasting glucose and plasma TNF-{alpha} remained higher 1 year postpartum compared to women with NGT studied previously. Skeletal muscle TNF-{alpha} mRNA was elevated 5 to 6-fold in GDM women, and remained higher 1 year postpartum. While levels of IR, IRS-1 and p85{alpha} improved postpartum, insulin-stimulated IR tyrosine phosphorylation and receptor tyrosine kinase activity did not significantly improve postpartum in GDM. The levels of 312Ser-IRS-1 also did not improve postpartum and correlated with TNF-{alpha} mRNA (r2=0.19, P<0.03), consistent with a state of sub-clinical inflammation and chronic skeletal muscle insulin resistance.

Conclusions.: These results suggest the mechanisms underlying chronic insulin resistance in GDM women may be driven by increased inflammation that impinges on the IR and IRS-1 signaling cascade in skeletal muscle. These findings have important implications for the health of GDM women during subsequent pregnancies as well as the risk for progression to type 2 diabetes.


Correspondence: jed.friedman{at}uchsc.edu

Key Words: insulin sensitivity • signal transduction • diabetes • obesity • inflammation


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2007 by the American Diabetes Association.